Breath therapeutics gmbh
WebApr 10, 2024 · Respiree is a digital therapeutics company providing personalized healthcare services for cardio-pulmonary disease management using a combination of proprietary breath-cardio sensors, AI and... WebOct 14, 2024 · Zambon’s Presence in the USA. Over the past few years, we have been steadily building our presence in the US through acquisition, R&D efforts, collaborative …
Breath therapeutics gmbh
Did you know?
WebOct 17, 2024 · Breath Therapeutics, a Zambon company Bonnie Ortega VP, Corporate Communications Ph. +1 858 245 3983 [email protected] FTI Consulting (media relations) Brett Pollard / Victoria Foster Mitchell ... WebMar 20, 2024 · MUNICH and MENLO PARK, Calif., March 20, 2024 /PRNewswire/ -- Breath Therapeutics, a private company developing advanced inhaled therapeutics in severe pulmonary orphan diseases, today...
WebMar 20, 2024 · Breath Therapeutics Announces Presentations at Upcoming Scientific Conferences The issuer is solely responsible for the content of this announcem... WebBreath Therapeutics' clinical development program is addressing the treatment of Bronchiolitis Obliterans Syndrome (BOS) in patients after lung transplantation. PARI Pharma, a leading nebulizer company, is strategic partner and technology licensee for the BOS development program. Breath Therapeutics is based in Munich and Frankfurt, …
WebBreath Therapeutics GmbH, Munich, Germany, District Court of Munich HRB 228231: Patents, Network, Financial information North Data Home Premium Services Data … WebFeb 20, 2024 · In July 2024, Breath Therapeutics was acquired by Zambon S.p.A, a multinational pharmaceutical company that focuses on innovation and development with …
WebMar 9, 2024 · Breath Therapeutics launched today with the closing of a 43.5 million euro Series A financing. The round was co-led by Gimv and Sofinnova Partners. They were joined by Gilde Healthcare. PARI Pharma provided financial support. Breath Therapeutics is a spin-out from PARI Pharma GmbH .
WebJul 25, 2024 · July 25, 2024. Italian pharma Zambon said today it has acquired Breath Therapeutics and its subsidiaries for up to €500 million (about $559 million), in a deal … trimethylamine in humansWeb5 free lookups per month. No credit card required. Work. München @ Breath Therapeutics B.V. München @ Breath Therapeutics B.V. @ PARI Pharma GmbH see more Global Clinical Trial Manager @ Breath Therapeutics B.V. see less tesco express sea street herne bayWebBreathing and Technology. The Breath Technologies digital healthcare platform enables the missing links you need to measure, record, practice, and share how you breathe and … trimethylamine herbicideWebApplicant: BREATH THERAPEUTICS GMBH Inventors: Martin KNOCH, Oliver DENK Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection. Patent number: 10857198 Abstract: The invention relates to cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection. In ... tesco express shotgateWebJul 25, 2024 · Breath Therapeutics was founded as a spin-out of German PARI Pharma GmbH, a specialist in equipment and inhalation solutions for lung and bronchial … trimethyl amine encapsulation in gum arabicWebBREATH THERAPEUTICS is a trademark owned by Breath Therapeutics GmbH and filed on Thursday, January 31, 2024 in the Pharmaceutical Products, Medical Instrument … trimethylamine for saleWebMar 20, 2024 · STARNBERG, Germany, March 20, 2024 /PRNewswire/ -- PARI Pharma, a company focused on optimization of drug-device combinations, has licensed its first-in-class inhalation development program for Bronchiolitis Obliterans Syndrome (BOS) to Breath Therapeutics GmbH (Breath Therapeutics, Munich, Germany) as their lead … trimethylamine hydrochloride melting point